Private Healthcare providers saw earnings decline sharply during the pandemic as most differed elective procedures. But is recovery in sight? Nadiah Wan, Group CEO of listed TMC Life Sciences Bhd gives us that answer whilst offering her views on the structural issues facing Malaysia's healthcare system and if public private partnerships are one solution.

Produced by: Moh Heng Ying

Presented by: Wong Shou Ning

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Corporates,  health policy

Tags:  thomson hospital,  healthcare reform,  healthcare costs,  tmc life sciences,  public-private partnership,